Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib in Relapsed/Refractory DLBCL and PTCL
NCT01431209Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Aug 2011
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruxolitinib in diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), sponsored by University of Nebraska. Started Aug 2011; status: completed.
02
Drugs
03
Conditions
diffuse large B-cell lymphoma (DLBCL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01431209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431209.